KIT and ovarian serous adenocarcinoma: Stemberger-Papic et al. [60] examined the expression of CD133+/CD117+ CSC markers in 64 serous ovarian cancer cases in HG serous carcinoma and peritoneal metastasis using IHC and found them relevant in disease progression and prognosis.